ARTICLE | Clinical News
99mTc-MIP-1404: Phase I data
July 15, 2013 7:00 AM UTC
An open-label, U.S. Phase I trial in about 24 prostate cancer patients scheduled for prostatectomy and/or extended pelvic lymph node dissection showed that a single IV dose of 99mTc-MIP-1404 was well ...